Biosimulation Global Market to Reach $6.13 Billion by 2026
/PRNewswire/ -- The "Biosimulation Global Market Report 2022, By Product, Application, End User" report has been added to ResearchAndMarkets.com's offering....
Stay updated with breaking news from Simulations Plus Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Biosimulation Global Market Report 2022, By Product, Application, End User" report has been added to ResearchAndMarkets.com's offering....
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Biosimulation Global Market Report 2022, By Product, Application, End User" report has been added to...
Extensive data sharing with large pharmaceutical partner will expand property prediction space and improve model performanceLANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today annou...
Nisa Investment Advisors LLC lowered its position in Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) by 3.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,200 shares of the technology company’s stock after selling 300 shares during the quarter. Nisa Investment Advisors […]
Several posters and oral presentations involved the use of MonolixSuite Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical